Neurology Minute
American Academy of Neurology
The Neurology Minute podcast delivers a brief daily summary of what you need to know in the field of neurology, the latest science focused on the brain, and timely topics explored by leading neurologists and neuroscientists. From the American Academy of Neurology and hosted by Stacey Clardy, MD, Ph.D., FAAN, with contributions by experts from the Neurology journals, Neurology Today, Continuum, and more.
Episodes
Mentioned books
Aug 2, 2019 • 2min
IVIG therapy and use
Dr. Rae Bacharach discusses intravenous or subcutaneous immunoglobulin therapy in immune-mediated neurologic conditions.
Aug 1, 2019 • 2min
Application of the McDonald criteria in the diagnosis of MS
Dr. Rae Bacharach discusses important points regarding application of the 2017 McDonald criteria for the diagnosis of MS.
Jul 31, 2019 • 2min
Oligoclonal bands and differentiation
Dr. Rae Bacharach discusses oligoclonal bands in MS and other conditions and differentiating types of bands.
Jul 30, 2019 • 2min
CDC's Guideline on Pediatric Mild Traumatic Brain Injury: Recommendations for Neurologists
Dr. Barbara Weissman discusses the main points from her Neurology: Clinical Practice paper on recommendations for neurologists on the CDC's Guideline on Pediatric Mild Traumatic Brain Injury.
Jul 29, 2019 • 2min
Thrombolysis Guided by Perfusion Imaging up to 9 Hours after Onset of Stroke
Dr. Geoffrey Donnan discusses the main takeaways from his study on thrombolysis guided by perfusion imaging up to 9 hours after onset of stroke. Read his NEJM article here: https://www.nejm.org/doi/pdf/10.1056/NEJMoa1813046.
Jul 25, 2019 • 2min
Continuum Pearls: Disease-Modifying Therapies in MS
Dr. Robert H. Gross discusses disease-modifying therapies in MS in the third part of a three-part series. To learn more, read the article "Monitoring, Switching, and Stopping Multiple Sclerosis Disease-Modifying Therapies" by Dr. Gross and Dr. John Corboy in the June 2019 Multiple Sclerosis and Other CNS Inflammatory Diseases issue of Continuum.
Jul 24, 2019 • 3min
Continuum Pearls: Disease-Modifying Therapies in MS, pt. 2
Dr. Robert H. Gross discusses disease-modifying therapies in MS in the second part of a three-part series. To learn more, read the article "Monitoring, Switching, and Stopping Multiple Sclerosis Disease-Modifying Therapies" by Dr. Gross and Dr. John Corboy in the June 2019 Multiple Sclerosis and Other CNS Inflammatory Diseases issue of Continuum.
Jul 23, 2019 • 1min
Determining clinically meaningful decline in preclinical Alzheimer disease
Dr. Philip Insel provides the main findings of his paper on determining clinically meaningful decline in preclinical Alzheimer disease.
Jul 22, 2019 • 2min
Targeting Huntington Expression in Patients with Huntington's Disease
Dr. Sarah Tabrizi discusses the main findings of her study on targeting Huntington expression in patients with Huntington's Disease. Ready the May 6th article in NEJM: https://www.nejm.org/doi/full/10.1056/NEJMoa1900907?query=recirc_curatedRelated_article
Jul 19, 2019 • 2min
Continuum Pearls: Disease-Modifying Therapies in MS
Dr. Robert H. Gross discusses disease-modifying therapies in MS in the first part of a three-part series. To learn more, read the article "Monitoring, Switching, and Stopping Multiple Sclerosis Disease-Modifying Therapies" by Dr. Gross and Dr. John Corboy in the June 2019 Multiple Sclerosis and Other CNS Inflammatory Diseases issue of Continuum.
